AI Targets Liver Cancer and Lung Disease
MSU AI Accelerates Drug Discovery for Cancer
Michigan State University researchers use deep learning to predict gene expression and treat liver and lung diseases.
A high-tech digital display showing molecular structures and gene data in a modern research laboratory environment.
Photo: Avantgarde News
Researchers at Michigan State University have developed a new deep-learning system to accelerate drug discovery [1]. The AI-driven approach predicts how various chemical structures influence gene expression within cells [1][2]. This study was published in the journal Cell [1]. ## AI Targets Liver Cancer and Lung Disease The system has already identified potential treatments for aggressive liver cancer and chronic lung disease [1][2]. This technology allows scientists to screen chemical compounds much faster than traditional laboratory methods [2]. By analyzing complex biological data, the AI suggests which drugs might be most effective for specific conditions [1].
Editorial notes
Transparency note
Drafted with LLM; human-edited
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
Related stories
View all
Topics
About the author
Avantgarde News Desk covers ai targets liver cancer and lung disease and editorial analysis for Avantgarde News.